Back to Exenatide research
exenatide glp 1 agonist other 2014-06 ClinicalTrials

Cycloset Explored as Add-on Therapy for Type 2 Diabetes on GLP-1s

Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy

Abstract

Effect of Cycloset on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled on GLP-1 Analogue Therapy NCT ID: NCT02299050 Status: COMPLETED Sponsor: The University of Texas Health Science Center at San Antonio Phase: PHASE4…

exenatide liraglutide glp 1 agonist dose mentioned protocol relevant
Source: clinicaltrials:NCT02299050 · Ingested 2026-04-29 · Digest: gemini-2.5-flash